Lake Street Maintains Buy on OptimizeRx, Lowers Price Target to $20
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Lake Street analyst Eric Martinuzzi maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $24 to $20.
Lake Street analyst Eric Martinuzzi maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $24 to $20.